One more comment regarding your interesting post:
Post# of 148170
I find it shocking that we might have only achieved a 20-30% mortality reduction at interim.
It's clearly a mistake to extrapolate eIND results from the very beginning of a pandemic -- to a RCT trial conducted at a later time that has inclusion, exclusion, and treatment protocols.
However, assuming your theory is true, it's hard to fathom how we fell from around a 50% reduction -- to somewhere potentially around half of that.
That's a big delta.